Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus

Sarah Cains, Andrew Shepherd, Mohammad Nabiuni, Penelope Jane Owen-Lynch, Jaleel Miyan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Fetal-onset hydrocephalus (HC), which affects between 1:500 and 1:5000 live human births, results from unequal production and drainage of cerebrospinal fluid (CSF) and is associated with abnormal development of the cerebral cortex leading to severe neurological deficits. We previously found that in the hydrocephalic Texas rat, the CSF of affected fetuses induced a cell cycle arrest in neural progenitor cells. Here, we show that alterations in folate metabolism in the CSF of the developing cerebrum are likely responsible for this effect. We identified 3 folate enzymes in the CSF and demonstrate that low levels of one of these, 10-formyltetrahydrofolate dehydrogenase, are associated with HC in the hydrocephalic Texas rat. Therefore, we tested whether supplementation with specific folate species would improve developmental outcome. After daily administration of a combination of tetrahydrofolic and 5-formyltetrahydrofolic acids to pregnant dams, there was a significant reduction in the incidence of HC and improved brain development. By contrast, supplementation with folic acid increased the incidence of congenital HC in this model. These results indicate the complexities of folate metabolism in the developing brain and suggest that folate imbalance leading to HC in the hydrocephalic Texas rat fetuses can be treated with maternal folate supplementation using specific folate metabolites and combinations thereof.

LanguageEnglish
Pages404-416
Number of pages13
JournalJournal of Neuropathology and Experimental Neurology
Volume68
Issue number4
DOIs
Publication statusPublished - 1 Apr 2009
Externally publishedYes

Fingerprint

Hydrocephalus
Folic Acid
Cerebrospinal Fluid
Incidence
Formyltetrahydrofolates
Fetus
Brain
Cerebrum
Live Birth
Cell Cycle Checkpoints
Cerebral Cortex
Stem Cells
Mothers
Enzymes

Cite this

@article{f3ba6c45641a4126b9f17bd41e3ad433,
title = "Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus",
abstract = "Fetal-onset hydrocephalus (HC), which affects between 1:500 and 1:5000 live human births, results from unequal production and drainage of cerebrospinal fluid (CSF) and is associated with abnormal development of the cerebral cortex leading to severe neurological deficits. We previously found that in the hydrocephalic Texas rat, the CSF of affected fetuses induced a cell cycle arrest in neural progenitor cells. Here, we show that alterations in folate metabolism in the CSF of the developing cerebrum are likely responsible for this effect. We identified 3 folate enzymes in the CSF and demonstrate that low levels of one of these, 10-formyltetrahydrofolate dehydrogenase, are associated with HC in the hydrocephalic Texas rat. Therefore, we tested whether supplementation with specific folate species would improve developmental outcome. After daily administration of a combination of tetrahydrofolic and 5-formyltetrahydrofolic acids to pregnant dams, there was a significant reduction in the incidence of HC and improved brain development. By contrast, supplementation with folic acid increased the incidence of congenital HC in this model. These results indicate the complexities of folate metabolism in the developing brain and suggest that folate imbalance leading to HC in the hydrocephalic Texas rat fetuses can be treated with maternal folate supplementation using specific folate metabolites and combinations thereof.",
keywords = "Cortex, Development, Fetus, Folate, H-Tx rat, Hydrocephalus, Supplement",
author = "Sarah Cains and Andrew Shepherd and Mohammad Nabiuni and Owen-Lynch, {Penelope Jane} and Jaleel Miyan",
year = "2009",
month = "4",
day = "1",
doi = "10.1097/NEN.0b013e31819e64a7",
language = "English",
volume = "68",
pages = "404--416",
journal = "Journal of Neuropathology and Experimental Neurology",
issn = "0022-3069",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus. / Cains, Sarah; Shepherd, Andrew; Nabiuni, Mohammad; Owen-Lynch, Penelope Jane; Miyan, Jaleel.

In: Journal of Neuropathology and Experimental Neurology, Vol. 68, No. 4, 01.04.2009, p. 404-416.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus

AU - Cains, Sarah

AU - Shepherd, Andrew

AU - Nabiuni, Mohammad

AU - Owen-Lynch, Penelope Jane

AU - Miyan, Jaleel

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Fetal-onset hydrocephalus (HC), which affects between 1:500 and 1:5000 live human births, results from unequal production and drainage of cerebrospinal fluid (CSF) and is associated with abnormal development of the cerebral cortex leading to severe neurological deficits. We previously found that in the hydrocephalic Texas rat, the CSF of affected fetuses induced a cell cycle arrest in neural progenitor cells. Here, we show that alterations in folate metabolism in the CSF of the developing cerebrum are likely responsible for this effect. We identified 3 folate enzymes in the CSF and demonstrate that low levels of one of these, 10-formyltetrahydrofolate dehydrogenase, are associated with HC in the hydrocephalic Texas rat. Therefore, we tested whether supplementation with specific folate species would improve developmental outcome. After daily administration of a combination of tetrahydrofolic and 5-formyltetrahydrofolic acids to pregnant dams, there was a significant reduction in the incidence of HC and improved brain development. By contrast, supplementation with folic acid increased the incidence of congenital HC in this model. These results indicate the complexities of folate metabolism in the developing brain and suggest that folate imbalance leading to HC in the hydrocephalic Texas rat fetuses can be treated with maternal folate supplementation using specific folate metabolites and combinations thereof.

AB - Fetal-onset hydrocephalus (HC), which affects between 1:500 and 1:5000 live human births, results from unequal production and drainage of cerebrospinal fluid (CSF) and is associated with abnormal development of the cerebral cortex leading to severe neurological deficits. We previously found that in the hydrocephalic Texas rat, the CSF of affected fetuses induced a cell cycle arrest in neural progenitor cells. Here, we show that alterations in folate metabolism in the CSF of the developing cerebrum are likely responsible for this effect. We identified 3 folate enzymes in the CSF and demonstrate that low levels of one of these, 10-formyltetrahydrofolate dehydrogenase, are associated with HC in the hydrocephalic Texas rat. Therefore, we tested whether supplementation with specific folate species would improve developmental outcome. After daily administration of a combination of tetrahydrofolic and 5-formyltetrahydrofolic acids to pregnant dams, there was a significant reduction in the incidence of HC and improved brain development. By contrast, supplementation with folic acid increased the incidence of congenital HC in this model. These results indicate the complexities of folate metabolism in the developing brain and suggest that folate imbalance leading to HC in the hydrocephalic Texas rat fetuses can be treated with maternal folate supplementation using specific folate metabolites and combinations thereof.

KW - Cortex

KW - Development

KW - Fetus

KW - Folate

KW - H-Tx rat

KW - Hydrocephalus

KW - Supplement

UR - http://www.scopus.com/inward/record.url?scp=65349184445&partnerID=8YFLogxK

U2 - 10.1097/NEN.0b013e31819e64a7

DO - 10.1097/NEN.0b013e31819e64a7

M3 - Article

VL - 68

SP - 404

EP - 416

JO - Journal of Neuropathology and Experimental Neurology

T2 - Journal of Neuropathology and Experimental Neurology

JF - Journal of Neuropathology and Experimental Neurology

SN - 0022-3069

IS - 4

ER -